ACRO Biomedical to Showcase Innovative Advanced Medical Devices at BIO Asia-Taiwan 2024

ACRO Biomedical will be participating in the upcoming BIO Asia-Taiwan 2024 exhibition in July, where it will unveil its latest advancements in high-end medical devices. The highlight of ACRO Biomedical's presentation will be its proprietary supercritical carbon dioxide decellularization technology, aimed at advancing tissue and organ repair and regeneration.

ACRO Biomedical's patented supercritical carbon dioxide decellularization technology can prepare non-recombinant natural collagen scaffolds without the need for chemical cleaning and cross-linking agents, and is suitable for various medical applications. This technology offers significant benefits by preparing decellularized materials that can effectively repair damaged tissues, provide an ideal healing environment, and avoid immune and allergic reactions. ACRO Biomedical’s products are applicable in orthopedics, dentistry, plastic surgery, neurosurgery, ophthalmology, general surgery, wound care, and many other fields.

With 71 global patents and 50 domestic and international certifications, ACRO Biomedical is actively expanding its presence in the global advanced biomedical materials market. In April, the company achieved a significant milestone by obtaining three Class III medical device licenses in Taiwan, demonstrating its leading-edge technology and exceptional quality. These three Class III medical devices include the "Hemostatic Collagen Matrix," "Hemostatic ADM Scaffold," and "Hemostatic ADM Paste."

These products are designed for internal and external wound management in major surgical procedures, effectively promoting hemostasis and wound healing. The "Hemostatic Collagen Matrix" is suitable for a wide range of wounds, including burns, trauma, ulcers, and various surgical wounds. The "Hemostatic ADM Scaffold," packaged in sterile powder form, can be directly applied to wounds to accelerate hemostasis and healing. The "Hemostatic ADM Paste," pre-filled in injection syringes, offers a convenient and effective treatment option for burns, trauma, ulcers, and surgical wounds.

ACRO Biomedical cordially invite all interested parties to visit its booth at BIO Asia-Taiwan 2024, located on the 4th floor at booth M430, to learn more about its latest technologies and products.